CK Life Sciences Int'l., (Holdings) Inc. (SEHK:775) entered into a sale and purchase agreement to acquire remaining 27.7% stake in Belvino Investments Trust from LANV Pty Ltd for AUD 27.8 million on September 7, 2018. The consideration is subject to adjustments. As per the terms, CK Life Sciences shall acquire 65.89 million units in Belvino Investments. Currently, CK Life Sciences holds 72.3% stake in Belvino Investments. Post-completion, CK Life Sciences shall hold the entire stake in Belvino Investments. It is intended that the consideration will be settled by internal resources. For the financial year ended December 31, 2017, Belvino Investments reported net profit before tax of AUD 16.3 million, net profit after tax of AUD 15.9 million and net assets value of AUD 85.9 million. The transaction is subject to approval by Treasurer of the Commonwealth of Australia and the New Zealand Overseas Investment Office. The board of CK Life Sciences has approved the transaction. The transaction shall be completed on the last business day of the month in which the conditions are satisfied, or on the last business day of the month following the conditions being satisfied, if the conditions are satisfied in the last five business days of the month.